Sangamo Therapeutics, Inc. (SGMO)

NASDAQ: SGMO · IEX Real-Time Price · USD

0.397

-0.006 (-1.49%)

At close: Jul 19, 2024, 4:00 PM

0.450

+0.053 (13.32%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Sangamo Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1997
Revenue	18.76	176.23	111.3	110.7	118.19	102.43	Upgrade
Revenue Growth (YoY)	-92.22%	58.34%	0.54%	-6.34%	15.39%	21.29%	Upgrade
Gross Profit	18.76	176.23	111.3	110.7	118.19	102.43	Upgrade
Selling, General & Admin	54.8	61.17	62.68	63.22	67.1	61.69	Upgrade
Research & Development	206.73	234.06	249.9	230.82	180.65	145.92	Upgrade
Other Operating Expenses	100.79	155.01	0	0	0	0	Upgrade
Operating Expenses	362.32	450.24	312.58	294.04	247.74	207.61	Upgrade
Operating Income	-343.57	-274.01	-201.28	-183.34	-129.55	-105.18	Upgrade
Other Expense / Income	-10.34	-11.1	-9.43	-5.36	-8.9	-9.99	Upgrade
Pretax Income	-333.22	-262.9	-191.85	-177.98	-120.65	-95.19	Upgrade
Income Tax	-5.17	-5.07	0.43	0.31	0.35	0	Upgrade
Net Income	-328.05	-257.83	-192.28	-178.29	-121	-95.19	Upgrade
Shares Outstanding (Basic)	180	174	154	145	134	112	Upgrade
Shares Outstanding (Diluted)	180	174	154	145	134	112	Upgrade
Shares Change	6.60%	13.02%	6.76%	7.53%	19.92%	15.65%	Upgrade
EPS (Basic)	-1.86	-1.48	-1.25	-1.23	-0.90	-0.85	Upgrade
EPS (Diluted)	-1.86	-1.48	-1.25	-1.23	-0.90	-0.85	Upgrade
Free Cash Flow	-218.16	-246	-243.8	-256.53	155.16	-165.08	Upgrade
Free Cash Flow Per Share	-1.21	-1.41	-1.58	-1.77	1.15	-1.47	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-1831.76%	-155.48%	-180.85%	-165.61%	-109.61%	-102.69%	Upgrade
Profit Margin	-1749.06%	-146.30%	-172.76%	-161.05%	-102.37%	-92.93%	Upgrade
Free Cash Flow Margin	-1163.15%	-139.59%	-219.05%	-231.73%	131.28%	-161.16%	Upgrade
EBITDA	-314.08	-240.71	-171.29	-160.34	-107.28	-85.58	Upgrade
EBITDA Margin	-1674.58%	-136.59%	-153.90%	-144.84%	-90.77%	-83.55%	Upgrade
Depreciation & Amortization	19.14	22.19	20.56	17.64	13.37	9.61	Upgrade
EBIT	-333.22	-262.9	-191.85	-177.98	-120.65	-95.19	Upgrade
EBIT Margin	-1776.61%	-149.18%	-172.37%	-160.78%	-102.08%	-92.93%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).